As an attempt at a co-operative Vherokior-Achura venture, VA-Pharma was founded YC124 atop InterBus' neutral-party sponsorship platform by entrepreneurial biochemists Rake'li Vatrige and Sula Arji, but the whole venture derailed as negotiations for InterBus' control of a planet-side delivery program fell apart. As funding ceased, the toss-up led to the small biochemical firm restructuring as a grey-sector research extension of Core Complexions Inc.